硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
人 TGFBR3 抗体对
试剂盒

人 TGFBR3 抗体对

01AB01610

Transforming growth factor beta receptor 3 (TGFBR3), also known as betaglycan, is a cell surface proteoglycan that binds various members of the TGF-beta superfamily. It is the most widely expressed TGF-beta receptor, with high affinity for all TGF-beta isoforms. TGFBR3 functions as a co-receptor, facilitating ligand binding to other TGF-beta receptors, and can exist in membrane-bound and soluble forms. The protein plays crucial roles in cell proliferation, differentiation, migration, and apoptosis. Its extracellular domain contains two TGF-beta binding sites, while the cytoplasmic domain interacts with scaffold proteins. TGFBR3 is essential for organ development and overall viability, as demonstrated in mouse knockout studies. In disease contexts, decreased TGFBR3 expression has been observed in various cancers, suggesting a potential tumor suppressor role. Additionally, TGFBR3 may be involved in the pathogenesis of systemic sclerosis and Marfan syndrome.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
TGFBR3
蛋白别名
transforming growth factor beta receptor 3; TGFBR3
UniProt
Q03167
物种
Human

产品详情

靶点名称
TGFBR3
蛋白名称
transforming growth factor beta receptor 3
蛋白别名
Transforming growth factor beta receptor type 3; TGF-beta receptor type 3; TGFR-3; Betaglycan; Transforming growth factor beta receptor III; TGF-beta receptor type III
靶点基因名
TGFBR3
UniProt
Q03167
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Transforming growth factor beta receptor 3 (TGFBR3), also known as betaglycan, is a cell surface proteoglycan that binds various members of the TGF-beta superfamily. It is the most widely expressed TGF-beta receptor, with high affinity for all TGF-beta isoforms. TGFBR3 functions as a co-receptor, facilitating ligand binding to other TGF-beta receptors, and can exist in membrane-bound and soluble forms. The protein plays crucial roles in cell proliferation, differentiation, migration, and apoptosis. Its extracellular domain contains two TGF-beta binding sites, while the cytoplasmic domain interacts with scaffold proteins. TGFBR3 is essential for organ development and overall viability, as demonstrated in mouse knockout studies. In disease contexts, decreased TGFBR3 expression has been observed in various cancers, suggesting a potential tumor suppressor role. Additionally, TGFBR3 may be involved in the pathogenesis of systemic sclerosis and Marfan syndrome.